Novartis's $7.8B mRNA Deal with Abogen | Pharma and Biotech Daily

Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the rapidly evolving landscape of drug development, where groundbreaking scientific advances and strategic corporate maneuvers are reshaping patient care and industry standards. The integration of artificial intelligence in drug discovery is gaining momentum, with companies like Xaira Therapeutics leading the way. By leveraging AI to enhanc...